| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 689.50B | 788.67B | 678.39B | 708.54B | 688.65B | 657.85B |
| Gross Profit | 121.03B | 25.65B | 119.63B | 109.57B | 97.32B | 88.86B |
| EBITDA | 103.66B | 114.73B | 126.39B | 122.52B | 105.54B | 105.03B |
| Net Income | 48.62B | 21.57B | 45.28B | 47.22B | 38.94B | 33.89B |
Balance Sheet | ||||||
| Total Assets | 3.60T | 3.84T | 3.57T | 3.39T | 3.15T | 2.95T |
| Cash, Cash Equivalents and Short-Term Investments | 658.79B | 670.70B | 614.71B | 632.27B | 576.19B | 395.18B |
| Total Debt | 2.85T | 3.01T | 2.81T | 2.69T | 2.52T | 2.38T |
| Total Liabilities | 3.07T | 3.28T | 3.04T | 2.91T | 2.74T | 2.58T |
| Stockholders Equity | 473.38B | 503.01B | 475.56B | 431.96B | 367.19B | 333.49B |
Cash Flow | ||||||
| Free Cash Flow | -85.20B | -122.76B | -85.20B | -79.34B | 104.88B | 126.61B |
| Operating Cash Flow | -81.77B | -119.33B | -81.77B | -76.07B | 107.56B | 128.79B |
| Investing Cash Flow | -35.66B | 1.17B | -35.66B | -3.06B | -12.39B | -15.67B |
| Financing Cash Flow | 97.99B | 171.76B | 97.99B | 131.80B | 84.04B | -101.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
76 Outperform | ¥14.51B | 8.19 | ― | 3.03% | 6.36% | 41.53% | |
65 Neutral | ¥1.15T | 8.84 | ― | 3.37% | 6.51% | 30.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥36.28B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
57 Neutral | ¥33.11B | 7.83 | ― | 4.66% | -8.90% | 9.92% | |
51 Neutral | ¥392.48B | 17.81 | ― | 3.62% | 16.26% | -52.33% |